TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

396 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicPeptide & GLP-1Mental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

136 studies on the map

Exercise Neuroprotection in Parkinson's Disease — Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV, Las VegasMolecular Signatures of Cutaneous Dupilumab Response — University of California, San Francisco, San FranciscoEvaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity — University of Connecticut, StorrsA Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring — Pfizer, New YorkParkinson's Foundation PD GENEration Genetic Registry — University of Alabama Birmingham, BirminghamDaily Amino Acid Supplementation for People With Parkinson's Disease — University of Connecticut, StorrsTargeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial — Sidney & Lois Eskenazi Hospital, IndianapolisTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD — Arizona State University, TempePhase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments — Domino's Farms, Ann ArborEffects of RAS on Gait in PD Patients With DBS — Johns Hopkins School of Medicine, BaltimoreVirtual tES Device Treatment for Parkinson's Disease Motor Symptoms — U LLC Headquarters, ClevelandSleep-specific DBS Therapy in Parkinson's Disease — University Of Minnesota, MinneapolisCortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing — Oregon Health and Science University, PortlandEffects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease — The Regenesis Project, Santa MonicaA Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH) — Arizona Liver Health, ChandlerTargeted Motor Learning to Improve Gait for Individuals With Parkinson Disease — University of North Carolina at Chapel Hill, Chapel HillNAFLD Clinical Care Pathway — Michael E. DeBakey VA Medical Center, Houston, TX, HoustonA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema — Northridge Clinical Trials, NorthridgeColonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder — Digestive Disease Associates, BranfordClinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — Johns Hopkins, BaltimoreA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestA Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH — GSK Investigational Site, ArcadiaChanges in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs — University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El PasoPrescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults — Kennesaw State Universityh, KennesawA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Banner Sun Health Research Institute, Sun CityEffects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients — NYIT College of Osteopathic Medicine, Old WestburyA Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery — University of Kentucky, LexingtonModerate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease — Atlanta VA Medical and Rehab Center, Decatur, GA, DecaturApathy in Parkinson Disease TMS Study — UNC-Chapel Hill, Cassidy Lab, Chapel HillA Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors — UConn Health, FarmingtonCharacterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. — University of Minnesota, MinneapolisEvaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaDevelopment of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis — University of Washington, SeattleSegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease — University of Texas Southwestern Medical Center, DallasA Study of Buntanetap in Participants With PD — University of Alabama at Birmingham, BirminghamMetabolic Profiling of Immune Responses in Immune-mediated Diseases — National Institutes of Health Clinical Center, BethesdaAndrogens and NAFLD Longitudinal Cohort Study — University of California San Francisco, San FranciscoA Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) — Arizona Liver Health, ChandlerCardamom and Topical Roseomonas in Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaPET Imaging Evaluation of [11C]SY08 — MGH, CharlestownRegistry for Systemic Eczema Treatments — Johns Hopkins University, BaltimoreA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications — Banner Alzheimer's Institute (BAI)-Phoenix, PhoenixImpact of a Biophoton Therapy on Patients With Brain Disorders — Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, ButlerA Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up — National Institutes of Health Clinical Center, BethesdaFeasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease — Richmond VA Medical Center, Richmond, VA, RichmondEvaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies — Institute for Neurodegenerative Disorders and XingImaging, LLC, New HavenStriatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation — University of Michigan, Ann ArborA Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease — Banner Sun Health Research Institute, Sun CityA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Barrow Neurological Institute, PhoenixSocial & QoL Behaviors in Parkinson's Disease — The George Washington University, Washington D.C.Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Galderma Investigational Site - 8893, BirminghamSimplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease — University of California San Francisco, San FranciscoGenetics and Aerobic Exercise to Slow Parkinson's Disease Trial — The Cleveland Clinic, ClevelandA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis — Investigational Site, Fountain ValleySpeech Learning and Speech Production in Parkinson's Disease — State University of New York at Buffalo, BuffaloSpinal Cord Stimulation for Parkinson's Disease Rehabilitation — Frazier Rehab Institute, LouisvilleA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema — Cahaba Dermatology & Skin Health Center, LLC, BirminghamA Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) — First OC Dermatology, IrvineOptimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease — Louis Stokes VA Medical Center, Cleveland, OH, ClevelandDupilumab De-escalation in Pediatric Atopic Dermatitis — Johns Hopkins Univerisity, BaltimoreSafety and Tolerability of Patterned Stimulation for DBS in the Home Setting — University of Florida, GainesvilleImpact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD) — Cincinnati Children's Hospital Medical Center, CincinnatiEndurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD — UT Health San Antonio- Dept. of Physical Therapy, San AntonioStereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor — Vanderbilt University Medical Center, NashvilleEffect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial — Brigham and Women's Hospital, BostonRegistry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Neurology and Pain Specialty, Aliso ViejoModifiable Variables in Parkinsonism (MVP) — Bastyr University, KenmoreNatural History and Genetics of Food Allergy and Related Conditions — National Institutes of Health Clinical Center, BethesdaA Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis — Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute, PhoenixColonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis — Oregon Health & Science University, PortlandA Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis — Akero Clinical Study Site, BirminghamStudy to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population — Syneos Health (remote site), MorrisvilleEffects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease — Movement Disorders Laboratory, MinneapolisOpen-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease — Invicro (dba Perceptive), New HavenNon-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) — National Institutes of Health Clinical Center, BethesdaAdaptive DBS to Offset STN Dysregulation During Exercise in PD — University of Colorado, AuroraA Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH) — Arizona Liver Health - Chandler, ChandlerA Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) — 89bio Clinical Study Site, BirminghamGlobus Pallidus Stimulation to Treat Insomnia — Mayo Clinic in Florida, JacksonvilleHarnessing Macrophage Lysosomal Lipid Metabolism in Obesity — University of Missouri School of Medicine, ColumbiaStudy in Parkinson Disease of Exercise — University of Alabama at Birmingham, BirminghamStimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD — University of Alabama at Birmingham, BirminghamA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis — Inmagene Site 1, LancasterHuman Models of Selective Insulin Resistance: Alpelisib, Part I — Columbia University Irving Medical Center, New YorkMechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease — Ann & Robert H Lurie Children's Hospital of Chicago, ChicagoStudy to Evaluate Soquelitinib in Participants With Moderate to Severe AD — Corvus Clinical Trials, South San FranciscoFlourish: Exploring the Early Infant Gut Microbiome — Seeding Labs INC, AustinPercept Transitions in FOG and PD — University of Minnesota, Movement Disorders Lab, MinneapolisPh 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 — Clinical Site 101, Fair LawnRemote Haptic Rehabilitation for Parkinson's Disease — Virginia Tech, BlacksburgFibrosis Lessens After Metabolic Surgery — Banner Health Center, PhoenixCottonseed Oil Versus Matched PUFA Effects — University of Georgia, AthensOnline Motor Control in People With Parkinson's Disease — University of Delaware, NewarkImaging Depression in Parkinson's Disease — Yale University, New HavenZesty Exercise System for Therapeutic Engagement — Emory University, 57 Executive Park S NE, Ste 200, AtlantaA Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Collaborative Neuroscience Network - CNS, Los AlamitosKetamine for Veterans With Parkinson's Disease — San Francisco VA Medical Center, San Francisco, CA, San FranciscoTreatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome — Icahn School of Medicine at Mount Sinai, New YorkA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH — 89bio Clinical Study Site, BirminghamA Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis — Hamilton Research, LLC, AlpharettaSAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Rocky Mountain Clinical Research, EnglewoodNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkVirtual Cycling Environments for Persons With Parkinson Disease — School of Health Professions, NewarkEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — Institute for Neurodegenerative Disorders, New HavenSodium in the Skin and Atopic Dermatitis — San Francisco VA Medical Center, San FranciscoLebrikizumab in Moderate-to-severe Atopic Dermatitis — Physioseq USA - CA, FolsomAdapting rHIRE and Sleep Monitoring in Parkinson's Disease — University of Colorado Anschutz Medical Campus, AuroraEvaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease — University of Colorado Anschutz, AuroraPsilocybin Therapy for Depression in Parkinson's Disease — University of California, San Francisco, San FranciscoA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH — GSK Investigational Site, ChandlerNASH AMPK Exercise Dosing (AMPED) Trial — Penn State Hershey Medical Center, HersheyAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2) — University of Nebraska Medical Center, OmaharTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease — West Virginia University Hospitals, MorgantownCorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry — CorEvitas, LLC, WalthamA Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis — Applied Research Center Of Arkansas /ID# 268547, Little RockIdentification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder — University of Minnesota, MinneapolisCortical Electrophysiology of Response Inhibition in Parkinson's Disease — Emory University Hospital, AtlantaLow Voltage Electrical Stimulation for Depression in Parkinson's Patients — University of South Alabama, MobileEndoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease — Brigham and Women's Hospital, BostonReal-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: — Parkinson's Disease and Movement Disorders Center - Orange County (South), Aliso ViejoTopical Treatment for Atopic Dermatitis — Wake Forest University Health Sciences, Winston-SalemPharmacy-led Transitions of Care Intervention to Improve Medication Adherence — University of Tennessee Medical Center, KnoxvilleInvestigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients — Boston University, BostonThe Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis — University of Pittsburgh Medical Center, PittsburghVestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease — University of Minnesota, Movement Disorders Lab, MinneapolisEthnic Differences in Mechanisms of Action of Dupilumab — University of Michigan, Ann ArborInspire HER: Inspiring the Heart and Emotions for Radical Health — University of Alabama at Birmingham, BirminghamBlood Flow Restriction for Optimizing Balance in Parkinson's Disease — University of Texas Health Science Center at San Antonio, San AntonioIntermittent Cottonseed Oil Consumption — University of Georgia, AthensA Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis — AllerVie Clinical Research, BirminghamRezdiffra Pregnancy and Lactation Registry — Madrigal Pharmaceuticals, West ConshohockenA Pilot Study of In-lab Dynamic Standing in Parkinson's Disease — Domino's Farms, Ann ArborSafety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis — Red River Research Partners, FargoSafety and Usability of the Cionic Neural Sleeve for Parkinson's Disease — Adapt Movement, CarlsbadFirst-in-Human Single and Multiple Dose of HL-400 — Pharmaron CPC, Inc., BaltimoreEffects of an Independent Walking Program With Walking Poles in People With Parkinson Disease — East Tennessee State University, Johnson City

Showing the 150 nearest — narrow your filters for fewer, closer studies.